{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:21:47Z","timestamp":1773094907575,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Metabolites derived from <jats:italic>N<\/jats:italic>\u22123 and <jats:italic>N<\/jats:italic>\u22126 polyunsaturated fatty acids (PUFAs) have both beneficial and detrimental effects on the heart. However, contribution of these lipid mediators to dilated cardiomyopathy (DCM)-associated mitochondrial dysfunction remains unknown. This study aimed to characterize DCM-specific alterations in the PUFA metabolome in conjunction with cardiac mitochondrial quality in human explanted heart tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Left ventricular tissues obtained from non-failing control (NFC) or DCM explanted hearts, were assessed for <jats:italic>N<\/jats:italic>\u22123 and <jats:italic>N<\/jats:italic>\u22126 PUFA metabolite levels using LC-MS\/MS. mRNA and protein expression of CYP2J2, CYP2C8 and epoxide hydrolase enzymes involved in <jats:italic>N<\/jats:italic>\u22123 and <jats:italic>N<\/jats:italic>\u22126 PUFA metabolism were quantified. Cardiac mitochondrial quality was assessed by transmission electron microscopy, measurement of respiratory chain complex activities and oxygen consumption (respiratory control ratio, RCR) during ADP-stimulated ATP production.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Formation of cardioprotective CYP-derived lipid mediators, epoxy fatty acids (EpFAs), and their corresponding diols were enhanced in DCM hearts. These findings were corroborated by increased expression of CYP2J2 and CYP2C8 enzymes, as well as microsomal and soluble epoxide hydrolase enzymes, suggesting enhanced metabolic flux and EpFA substrate turnover. DCM hearts demonstrated marked damage to mitochondrial ultrastructure and attenuated mitochondrial function. Incubation of fresh DCM cardiac fibers with the protective EpFA, 19,20-EDP, significantly improved mitochondrial function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The current study demonstrates that increased expressions of CYP-epoxygenase enzymes and epoxide hydrolases in the DCM heart correspond with enhanced PUFA-derived EpFA turnover. This is accompanied by severe mitochondrial functional impairment which can be rescued by the administration of exogenous EpFAs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.879209","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T04:57:15Z","timestamp":1652936235000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy"],"prefix":"10.3389","volume":"9","author":[{"given":"Deanna K.","family":"Sosnowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Lockhart","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.","family":"Darwesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedieh","family":"Keshavarz-Bahaghighat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anissa","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Edin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin Y.","family":"Oudit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Seubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","article-title":"Cytochrome P450-derived eicosanoids and heart function","volume":"179","author":"Jamieson","year":"2017","journal-title":"Pharmacol Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3390\/ijms22041691","article-title":"Soluble epoxide hydrolase in aged female mice and human explanted hearts following ischemic injury","volume":"22","author":"Jamieson","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3389\/fphar.2018.01572","article-title":"Deficiency of soluble epoxide hydrolase protects cardiac function impaired by LPS-induced acute inflammation","volume":"9","author":"Samokhvalov","year":"2019","journal-title":"Front Pharmacol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1038\/s41598-020-62174-w","article-title":"CYP2J2 modulates diverse transcriptional programs in adult human cardiomyocytes","volume":"10","author":"Evangelista","year":"2020","journal-title":"Sci Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e15666","DOI":"10.1371\/journal.pone.0015666","article-title":"Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism","volume":"5","author":"Michaud","year":"2010","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3389\/fcell.2020.624216","article-title":"Mitochondrial function and dysfunction in dilated cardiomyopathy","volume":"8","author":"Ramaccini","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/metabo10060254","article-title":"The cardiac lipidome in models of cardiovascular disease","volume":"10","author":"Tomczyk","year":"2020","journal-title":"Metabolites"},{"key":"B10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1161\/CIRCHEARTFAILURE.113.000744","article-title":"Delta-6-desaturase links polyunsaturated fatty acid metabolism with phospholipid remodeling and disease progression in heart failure","volume":"7","author":"Le Catherine","year":"2014","journal-title":"Circu Heart Fail."},{"key":"B11","doi-asserted-by":"publisher","first-page":"165995","DOI":"10.1016\/j.bbadis.2020.165995","article-title":"The human explanted heart program: a translational bridge for cardiovascular medicine","volume":"1867","author":"Zhang","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1096\/fj.11-188300","article-title":"Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart","volume":"25","author":"Edin","year":"2011","journal-title":"FASEB J."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/eci.12549","article-title":"Determinants of ventricular arrhythmias in human explanted hearts with dilated cardiomyopathy","volume":"45","author":"Parajuli","year":"2015","journal-title":"Eur J Clin Invest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.3390\/ijms23042050","article-title":"Transcriptomic signatures of end-stage human dilated cardiomyopathy hearts with and without left ventricular assist device support","volume":"23","author":"Parikh","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.trsl.2016.02.006","article-title":"Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure","volume":"172","author":"Sakamuri","year":"2016","journal-title":"Transl Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fphys.2020.00048","article-title":"Age and sex differences in hearts of soluble epoxide hydrolase null mice","volume":"11","author":"Jamieson","year":"2020","journal-title":"Front Physiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3390\/cells10092177","article-title":"A universal approach to analyzing transmission electron microscopy with ImageJ","volume":"10","author":"Lam","year":"2021","journal-title":"Cells."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nprot.2012.058","article-title":"Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells","volume":"7","author":"Spinazzi","year":"2012","journal-title":"Nat Protoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nprot.2008.61","article-title":"Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells","volume":"3","author":"Kuznetsov","year":"2008","journal-title":"Nat Protoc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.3390\/ijms20143502","article-title":"Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase ameliorates cardiac ischemia\/reperfusion injury by attenuating NLRP3 inflammasome activation","volume":"20","author":"Darwesh","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/2042018810375656","article-title":"Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis","volume":"1","author":"Vangaveti","year":"2010","journal-title":"Ther Adv Endocrinol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1124\/dmd.119.086611","article-title":"Overview of the components of cardiac metabolism","volume":"47","author":"Hausner","year":"2019","journal-title":"Drug Metab Dispos."},{"key":"B23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1124\/dmd.106.012823","article-title":"Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues","volume":"35","author":"Delozier","year":"2007","journal-title":"Drug Metab Dispos."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/dmd.117.078964","article-title":"Cytochrome P450 2J2: potential role in drug metabolism and cardiotoxicity","volume":"46","author":"Solanki","year":"2018","journal-title":"Drug Metab Dispos."},{"key":"B25","doi-asserted-by":"publisher","first-page":"584800","DOI":"10.3389\/fcell.2020.584800","article-title":"Mitochondrial dynamics in adult cardiomyocytes and heart diseases","volume":"8","author":"Li","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1469-7793.2000.00057.x","article-title":"Mitochondria and calcium: from cell signalling to cell death","volume":"529","author":"Duchen","year":"2000","journal-title":"J Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0160380","DOI":"10.1371\/journal.pone.0160380","article-title":"Novel roles of epoxyeicosanoids in regulating cardiac mitochondria","volume":"11","author":"El-Sikhry","year":"2016","journal-title":"PLoS ONE."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3390\/cells9071565","article-title":"Mitochondrial dysfunction and inflammaging in heart failure: novel roles of CYP-derived epoxylipids","volume":"9","author":"Keshavarz-Bahaghighat","year":"2020","journal-title":"Cells"},{"key":"B29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cbi.2019.04.037","article-title":"Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system","volume":"308","author":"Darwesh","year":"2019","journal-title":"Chem Biol Interact."},{"key":"B30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/eurheartj\/ehaa841","article-title":"Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences","volume":"42","author":"Verdonschot","year":"2021","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome p450 enzymes in the bioactivation of polyunsaturated Fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv Exp Med Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e3000739","DOI":"10.1371\/journal.pbio.3000739","article-title":"Increased prostaglandin-D2 in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation","volume":"18","author":"Stelling","year":"2020","journal-title":"PLoS Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e003291","DOI":"10.1161\/CIRCHEARTFAILURE.116.003291","article-title":"Prostaglandin E2 reduces cardiac contractility via EP3 receptor","volume":"9","author":"Gu","year":"2016","journal-title":"Circul Heart Fail."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/01.CIR.0000143832.91812.60","article-title":"Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2","volume":"110","author":"Spiecker","year":"2004","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/pharmaceutics9040044","article-title":"Altered protein expression of cardiac CYP2J and hepatic CYP2C, CYP4A, and CYP4F in a mouse model of type II diabetes\u2014a link in the onset and development of cardiovascular disease?","volume":"9","author":"Drolet","year":"2017","journal-title":"Pharmaceutics."},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-50621-6_5","article-title":"Epoxy fatty acids are promising targets for treatment of pain, cardiovascular disease and other indications characterized by mitochondrial dysfunction, endoplasmic stress and inflammation","volume":"1274","author":"McReynolds","year":"2020","journal-title":"Adv Exp Med Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.prostaglandins.2006.05.017","article-title":"Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia\/reperfusion injury","volume":"82","author":"Seubert","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0304-3940(97)00646-0","article-title":"Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex","volume":"233","author":"Saluja","year":"1997","journal-title":"Neurosci Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.3390\/ijms22094993","article-title":"Relative importance of soluble and microsomal epoxide hydrolases for the hydrolysis of epoxy-fatty acids in human tissues","volume":"22","author":"Morisseau","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat Rev Drug Discov."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/hmg\/ddl085","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: an atherosclerosis risk in communities (ARIC) study","volume":"15","author":"Lee","year":"2006","journal-title":"Hum Mol Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/01.CIR.95.5.1115","article-title":"Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans","volume":"95","author":"Hornig","year":"1997","journal-title":"Circulation."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.cjca.2016.03.017","article-title":"Sex differences in the biology and pathology of the aging heart","volume":"32","author":"Keller","year":"2016","journal-title":"Can J Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","article-title":"Sex\/gender differences in cardiovascular disease prevention what a difference a decade makes","volume":"124","author":"Mosca","year":"2011","journal-title":"Circulation."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jacc.2005.05.067","article-title":"Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy","volume":"46","author":"Sheppard","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"H1726","DOI":"10.1152\/ajpheart.00783.2011","article-title":"Testosterone and interleukin-1\u03b2 increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n","volume":"302","author":"Coronado","year":"2012","journal-title":"Am J Physiol Heart Circul Physiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"108046","DOI":"10.1016\/j.pharmthera.2021.108046","article-title":"Sex differences in eicosanoid formation and metabolism: a possible mediator of sex discrepancies in cardiovascular diseases","volume":"2021","author":"Gerges","year":"2021","journal-title":"Pharmacol Ther."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.879209\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T04:57:17Z","timestamp":1652936237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.879209\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":47,"alternative-id":["10.3389\/fcvm.2022.879209"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.879209","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"article-number":"879209"}}